E-MEXP-232 - Platform comparison and transcription profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 ?M resveratrol to evaluate Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A)

Status
Submitted on 20 December 2004, released on 8 March 2005, last updated on 2 May 2014
Organism
Homo sapiens
Samples (4)
Arrays (2)
Protocols (12)
Description
Evaluation of two commercial microarray platforms (Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A). Both platforms have been tested on gene expression profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 µM resveratrol.
Experiment types
transcription profiling by array, array platform variation, compound treatment
Contact
Citation
Strategies for comparing gene expression profiles from different microarray platforms: Application to a case-control experiment. Severgnini M, Bicciato S, Mangano E, Scarlatti F, Mezzelani A, Mattioli M, Ghidoni R, Peano C, Bonnal R, Viti F, Milanesi L, De Bellis G, Battaglia C. Anal Biochem 353:43-56 (2006), Europe PMC 16624241
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-MEXP-232.idf.txt
Sample and data relationshipE-MEXP-232.sdrf.txt
Raw data (1)E-MEXP-232.raw.1.zip
Processed data (1)E-MEXP-232.processed.1.zip
Array designsA-AFFY-33.adf.txt, A-MEXP-162.adf.txt
Links